Bivium Biosciences is a biotechnology company focused on developing breakthrough treatments for neurodegenerative diseases such as Multiple Sclerosis (MS) and Alzheimer's Disease (AD). The company’s innovative approach targets the root causes of neurodegeneration, aiming to halt disease progression and offer precise neuroprotection by addressing the primary mechanisms that drive neuronal injury.
With a leadership team led by seasoned experts in the healthcare and biopharmaceutical industries, Bivium Biosciences is committed to creating therapies that go beyond traditional methods, targeting key drivers of neuronal damage rather than just secondary processes like inflammation or plaque buildup. By doing so, Bivium aims to reshape the landscape of neurodegenerative disease treatment.
Company Details
- Employees
- 1
- Address
- 208 Palmer Alley, Newtown,pennsylvania 18940,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://biviumbiosciences.com
- Keywords
- IT Consulting.
- HQ
- Newtown, Pennsylvania
Bivium Biosciences Questions
Bivium Biosciences's website is http://biviumbiosciences.com
Bivium Biosciences's LinkedIn profile is https://www.linkedin.com/company/bivium-biosciences
Bivium Biosciences has
1 employees.
View email and phone details for 1
employees at Bivium Biosciences.
Bivium Biosciences's industry is
Biotechnology Research
Bivium Biosciences's top competitors are
Vera Therapeutics, Inc.,
Jabez Biosciences,
Ardelyx, Inc.,
Evely Health,
Zettahealth Solutions, Llc,
Cloudivus, Llc,
Remi Therapeutics,
Nök Therapeutics,
Imvirtus, Inc,
Scholar Rock.
Bivium Biosciences's categories are Biotechnology Research
